Trials / Completed
CompletedNCT01304433
Safety Profile of Hydroxyethyl Starch
Evaluation on the Safety Profile of Hydroxyethyl Starch (HES) 130/0.42
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- B. Braun Melsungen AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is primarily aimed to collect further data on the safety of the investigational product in a large patient population when used in routine clinical practice in the Asian-Pacific region.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Venofundin 6% / Tetraspan 6% | Venofundin 6% / Tetraspan 6% |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2011-02-25
- Last updated
- 2011-10-28
Locations
6 sites across 2 countries: China, Malaysia
Source: ClinicalTrials.gov record NCT01304433. Inclusion in this directory is not an endorsement.